IL33 and chronic obstructive pulmonary disease: These findings are supported by increased expression of AP-2 (TFAP2A, TFAP2C) and AP-1 (FOS and JUN) TFs in lung tissue and by nuclear colocalization of IL-33 and phosphorylated AP-2γ protein in COPD airways.